aTyr Pharma | LIFE - Capitaux D'Emprunt





Capitaux D'Emprunt Changement Date
Alterity Therapeutics Limited AUD 43.68K 59.53K 2025-12
Ardelyx USD 203.52M 683K 2026-03
aTyr Pharma USD 1.72M 10.79M 2026-03
Biogen USD 7.29B 1B 2026-06
Bristol-Myers Squibb USD 42.09B 59M 2026-06
Cipla INR 3.82B 840.2M 2026-03
Clal Biotechnology ILS 25.96M 18.48M 2023-12
Compugen USD 0 0 2024-12
CSL USD 10.42B 273M 2025-12
Curis USD 29.43M 10.69M 2024-06
GlaxoSmithKline GBP 13.95B 65M 2026-06
Grifols EUR 9.95B 722.93M 2025-12
Lakefront Biotherapeutics EUR 4.77M 78K 2026-06
Novartis USD 37.49B 42M 2026-06
Roche Holding CHF 25.22B 2.21B 2026-06
United Therapeutics USD 100M 100M 2024-06